The Impact of Non-Donor-Specific HLA Antibodies on Antibody-Mediated Rejection in Pediatric Kidney Transplant Recipients
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26125870 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Maria Sangermano und 7 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Nephrology, Department of Women's and Children's Health, Padua University Hospital, 35128 Padua, Italy. Hauptthemen laut MEDLINE: Kidney Transplantation, HLA Antigens, Graft Rejection, Isoantibodies. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
While the pathogenic role of donor-specific anti-HLA antibodies (DSAs) in long-term immune-mediated injury after kidney transplantation is well established, the clinical relevance of non-donor-specific antibodies (nDSAs), also detected in transplant recipients, remains a subject of debate. This retrospective study evaluated the prognostic value of nDSAs in 92 pediatric kidney transplant recipients (89.1%, 9.8%, and 1.1% for first, second, and third transplants, respectively) at the University Hospital of Padua between January 2015 and December 2022, investigating the association between antibody development and clinical outcomes, including graft function, rejection episodes, and viral infections. Clinical, immunological, virological, and histopathological data were collected at 6, 12, and 24 months post-transplant. Antibody prevalence increased over time, with nDSAs being more frequent than DSAs at all timepoints. The combined presence of DSAs and nDSAs significantly increased the risk of ABMR (HR = 45.10; p < 0.001). Isolated nDSAs and DSAs were also associated with an increased risk of ABMR (HR = 6.43 and 12.10, respectively), suggesting a synergistic alloimmune effect. Viral infections also emerged as relevant cofactors in humoral alloimmunity. EBV viremia and intrarenal Parvovirus B19 (PVB19) infection were significantly associated with ABMR, with PVB19 also correlating with nDSA formation. In conclusion, integrated immunological and virological monitoring may support risk stratification and guide individualized post-transplant management. Larger multicenter studies are warranted to define the long-term impact of nDSAs in pediatric kidney transplantation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pediatric Nephrology, Department of Women's and Children's Health, Padua University Hospital, 35128 Padua, Italy.
- Laboratory of Immunopathology and Molecular Biology of the Kidney, Department of Women's and Children's Health, Padua University Hospital, 35128 Padua, Italy.
ORCID-Profile: Maria Sangermano, Susanna Negrisolo, Nicola Bertazza Partigiani, Elisa Benetti
Zitieren
APA
Sangermano, M., Soncin, V., Auciello, M., Ciabattoni, F., Negrisolo, S., Marinelli, E., Bertazza Partigiani, N., & Benetti, E. (2025). The Impact of Non-Donor-Specific HLA Antibodies on Antibody-Mediated Rejection in Pediatric Kidney Transplant Recipients. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26125870
Vancouver
Sangermano M, Soncin V, Auciello M, Ciabattoni F, Negrisolo S, Marinelli E, et al. The Impact of Non-Donor-Specific HLA Antibodies on Antibody-Mediated Rejection in Pediatric Kidney Transplant Recipients. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26125870
BibTeX
@article{Sangermano2025,
author = {Sangermano, Maria and Soncin, Vittoria and Auciello, Maria and Ciabattoni, Francesco and Negrisolo, Susanna and Marinelli, Elena and Bertazza Partigiani, Nicola and Benetti, Elisa},
title = {The Impact of Non-Donor-Specific HLA Antibodies on Antibody-Mediated Rejection in Pediatric Kidney Transplant Recipients},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26125870}
}
EUVIMED